Zobrazeno 1 - 10
of 162
pro vyhledávání: '"J.-C. Mani"'
Autor:
Elizabeth Fischer, S Lecoanet-Henchoz, J C Mani, J.Y. Bonnefoy, Véronique Frémeaux-Bacchi, Michel D. Kazatchkine
Publikováno v:
International Immunology. 10:1459-1466
A soluble form of CD21 (sCD21) of 135 kDa is spontaneously released by human B and T lymphocytes upon shedding of the extracellular domain of the molecule. By Western blotting, we have now identified two forms of sCD21 of Mr 135 and 90 kDa in normal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c578ab622ee3dd202e124491e860c1de
https://doi.org/10.1093/intimm/10.10.1459
https://doi.org/10.1093/intimm/10.10.1459
Autor:
G Badouaille, Xavier Jeunemaitre, Thanh Tam Guyene, Anne-Paule Gimenez-Roqueplo, Joël Ménard, J.-C. Mani, Bernard Pau, P. Cohen, D Simon, Pierre Corvol
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 81:3505-3512
The common M235T mutation of human angiotensinogen has been shown to be associated with a 10-20% increase in plasma angiotensinOgen level and increased frequency of essential and pregnancy-induced hypertension. The detection of such a common factor i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd2fca58fffab3bc90f1521d39451aa3
https://doi.org/10.1210/jcem.81.10.8855793
https://doi.org/10.1210/jcem.81.10.8855793
Publikováno v:
Journal of Biological Chemistry. 269:29435-29443
We have used a monoclonal antibody-based binding procedure to determine the dissociation constants of the interactions between the essential antithrombin-binding pentasaccharide and a series of 13 distinct N- and C-terminal antithrombin substitution
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a6c118f1a3f7d7445d5c66d25c29e15
https://doi.org/10.1016/s0021-9258(18)43898-7
https://doi.org/10.1016/s0021-9258(18)43898-7
Autor:
Martine Piechaczyk, Djoko Wahyono, C Girard, J M Scherrmann, J Grenier, Jean-Marie Bastide, B. Pau, J C Mani
Publikováno v:
Therapeutic Drug Monitoring. 13:113-119
Four digoxin radioimmunoassays (RIA) were evaluated using four antidigoxin monoclonal antibodies (MAb) with different binding specificities for digoxin metabolites and other glycosides. These RIA have been used to measure the apparent digoxin concent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95a1d9be3b91626250890168e946d764
https://doi.org/10.1097/00007691-199103000-00005
https://doi.org/10.1097/00007691-199103000-00005
Publikováno v:
Clinical science (London, England : 1979). 98(4)
beta(2)-Microglobulin, a 12 kDa protein forming part of the class I HLA (histocompatibility locus antigen) major histocompatibility complex, has been used as a prognosis factor for multiple myeloma and as a marker of renal function, and has been show
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1aa46e574c7ee1338545bc1cee0889a4
https://pubmed.ncbi.nlm.nih.gov/10731476
https://pubmed.ncbi.nlm.nih.gov/10731476
Publikováno v:
The Journal of biological chemistry. 275(3)
Thyroglobulin (TG) is secreted by the thyrocytes into the follicular lumen of the thyroid. After maturation and hormone formation, TG is endocytosed and delivered to lysosomes. Quality control mechanisms may occur during this bidirectional traffic si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::94668e88d3e0b5d2f96bb4f98769913e
https://pubmed.ncbi.nlm.nih.gov/10636893
https://pubmed.ncbi.nlm.nih.gov/10636893
Publikováno v:
Blood. 93(12)
It is widely accepted that the serum of healthy individuals contains natural antibodies only against those blood group A or B antigens that are not expressed on the individual's red blood cells. The mechanisms involved in tolerance to autologous bloo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::195500b0fbbf94b6f242a64b130800dd
https://pubmed.ncbi.nlm.nih.gov/10361140
https://pubmed.ncbi.nlm.nih.gov/10361140
Autor:
T L, Vassilev, M D, Kazatchkine, J P, Duong Van Huyen, M, Mekrache, E, Bonnin, J C, Mani, C, Lecroubier, D, Korinth, D, Baruch, F, Schriever, S V, Kaveri
Publikováno v:
Blood. 93(11)
Intravenous immunoglobulin (IVIg) therapy is associated with a broad range of immunomodulatory activities. Several of the postulated mechanisms of IVIg action relate to the presence of antibodies to molecules relevant for regulation of the immune res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8f93347e339214230571ac5cf5d9569e
https://pubmed.ncbi.nlm.nih.gov/10339467
https://pubmed.ncbi.nlm.nih.gov/10339467
Publikováno v:
European cytokine network. 10(1)
Interleukin-6 (IL-6) is used as a growth factor by various tumor cells. It binds to a gp80 specific receptor (IL-6R) and then to a gp130 transducing chain. Both receptor chains are released as soluble functional proteins which circulate in biological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bcff7ec37d3ec1c874fec141bca204e4
https://pubmed.ncbi.nlm.nih.gov/10210772
https://pubmed.ncbi.nlm.nih.gov/10210772
Publikováno v:
International journal of cancer. 80(6)
The mannose-6-phosphate/insulin-like growth-factor-II receptor (M6P/IGFII-R) involved in trafficking of newly synthesized lysosomal enzymes, degradation of IGFII and activation of TGFbetaI, was suggested as being coded by a tumor-suppressor gene. No
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bdf392c98bd3265cb6ebace8584fb5b9
https://pubmed.ncbi.nlm.nih.gov/10074924
https://pubmed.ncbi.nlm.nih.gov/10074924